On Monday, Elon Musk, the billionaire founder of Neuralink, announced that the first human received an implant from the brain-chip company on Sunday and is recovering from a successful implantation.
Musk announced the success in a post on social media platform X, after the Food and Drug Administration had given the company clearance last year to conduct its first trial to test its implant on humans.
“The first human received an implant from @Neuralink yesterday and is recovering well,” Musk wrote on the platform. “Initial results show promising neuron spike detection.”
The company’s PRIME Study is a trial for its wireless brain-computer interface and evaluates the safety of the implant and surgical robot.
The study intends to assess the functionality of the interface, which is intended to enable people with quadriplegia, paralysis of all four limbs, to control devices with their thoughts, the company’s website says.
“We are excited to share that we have received the FDA’s approval to launch our first-in-human clinical study!” Neuralink wrote on X after they first received approval. “This is the result of incredible work by the Neuralink team in close collaboration with the FDA and represents an important first step that will one day allow our technology to help many people.”
Musk has previously said that, as the technology develops, the technology could be used to treat neurological disorders, such as paralysis and blindness by bridging signals between existing neurons, and would allow humans to save and replay memories.
“We want to be extremely careful and certain that it will work well before putting a device into a human,” Musk said after the company’s first request for human trials was rejected in 2022. “The progress at first, particularly as it applies to humans, will seem perhaps agonizingly slow, but we are doing all of the things to bring it to scale in parallel. So, in theory, progress should be exponential.”
Scroll down to leave a comment and share your thoughts.